DE60112756D1 - Racecadotril enthaltende trockene pulverformulierung - Google Patents

Racecadotril enthaltende trockene pulverformulierung

Info

Publication number
DE60112756D1
DE60112756D1 DE60112756T DE60112756T DE60112756D1 DE 60112756 D1 DE60112756 D1 DE 60112756D1 DE 60112756 T DE60112756 T DE 60112756T DE 60112756 T DE60112756 T DE 60112756T DE 60112756 D1 DE60112756 D1 DE 60112756D1
Authority
DE
Germany
Prior art keywords
dry powder
racecadotril
powder formulation
containing dry
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60112756T
Other languages
English (en)
Other versions
DE60112756T2 (de
Inventor
Jeanne-Marie Lecomte
Jean-Charles Schwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioprojet SC
Original Assignee
Bioprojet SC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet SC filed Critical Bioprojet SC
Application granted granted Critical
Publication of DE60112756D1 publication Critical patent/DE60112756D1/de
Publication of DE60112756T2 publication Critical patent/DE60112756T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60112756T 2000-06-23 2001-06-22 Racecadotril enthaltende trockene pulverformulierung Expired - Lifetime DE60112756T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00401799 2000-06-23
EP00401799 2000-06-23
PCT/EP2001/007086 WO2001097801A2 (en) 2000-06-23 2001-06-22 Dry powder formulation comprising racecadotril

Publications (2)

Publication Number Publication Date
DE60112756D1 true DE60112756D1 (de) 2005-09-22
DE60112756T2 DE60112756T2 (de) 2006-06-08

Family

ID=8173739

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60112756T Expired - Lifetime DE60112756T2 (de) 2000-06-23 2001-06-22 Racecadotril enthaltende trockene pulverformulierung

Country Status (13)

Country Link
US (1) US6919093B2 (de)
EP (1) EP1294372B1 (de)
CN (2) CN102151247A (de)
AT (1) ATE301999T1 (de)
AU (1) AU2001289606A1 (de)
BG (1) BG66212B1 (de)
CA (1) CA2415957C (de)
CZ (1) CZ299591B6 (de)
DE (1) DE60112756T2 (de)
DK (1) DK1294372T3 (de)
ES (1) ES2247163T3 (de)
SK (1) SK287819B6 (de)
WO (1) WO2001097801A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
CN101103960B (zh) * 2006-07-14 2010-12-08 海南盛科生命科学研究院 一种含有消旋卡多曲的干混悬剂及其制备方法
EP2462922A1 (de) 2010-12-10 2012-06-13 Bioprojet Neue Darreichungsform für Enkephalinasehemmer
CN102166197B (zh) * 2011-04-25 2012-09-05 四川百利药业有限责任公司 消旋卡多曲颗粒及其生产工艺
EP2768537B1 (de) * 2011-10-18 2019-02-20 Purdue Pharma LP Acrylpolymerformulierungen
RU2632441C2 (ru) 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила
US9114171B2 (en) 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
PT2866802T (pt) 2012-06-28 2016-09-05 Johnson & Johnson Consumer Inc Composições líquidas racecadotril
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
TR201801726T4 (tr) * 2012-12-26 2018-03-21 Ilko Ilac Sanayi Veticaret A S Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇.
EP2918268A1 (de) 2014-03-10 2015-09-16 Galenicum Health S.L. Pharmazeutische Zusammensetzungen mit aktiven Mittel
ES2555484T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
EP3558272A1 (de) 2016-12-23 2019-10-30 Hermes Arzneimittel GmbH Orale pharmazeutische zusammensetzung mit verbesserten geschmacksmaskierenden eigenschaften
WO2018163195A1 (en) 2017-03-06 2018-09-13 Athena Drug Delivery Solutions Pvt Ltd. A pharmaceutical composition comprising racecadotril and process for preparing the same
CN109589310A (zh) * 2017-10-01 2019-04-09 北京万全德众医药生物技术有限公司 消旋卡多曲干混悬剂及其制备方法
GB2586201B (en) * 2019-05-14 2023-05-24 Orbit Pharmaceuticals A stable powder formulation of racecadotril
EP4056171A1 (de) 2021-03-12 2022-09-14 Athena Pharmaceutiques SAS Geschmacksmaskierte racecadotril-tablettenzusammensetzung und verfahren zu ihrer herstellung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
ZA919510B (en) * 1990-12-05 1992-10-28 Smithkline Beecham Corp Pharmaceutical compositions
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
EP0914822A4 (de) * 1996-03-14 2002-08-07 Bayer Ag Schnell freisetzende mikrodispergierbare ecadotril zubereitung
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations

Also Published As

Publication number Publication date
CN1635884A (zh) 2005-07-06
DE60112756T2 (de) 2006-06-08
CZ299591B6 (cs) 2008-09-10
BG66212B1 (bg) 2012-05-31
WO2001097801A3 (en) 2002-09-12
BG107481A (bg) 2003-09-30
CZ2003185A3 (cs) 2003-05-14
CA2415957C (en) 2010-08-10
ES2247163T3 (es) 2006-03-01
CA2415957A1 (en) 2001-12-27
WO2001097801A2 (en) 2001-12-27
ATE301999T1 (de) 2005-09-15
EP1294372A2 (de) 2003-03-26
SK287819B6 (sk) 2011-11-04
DK1294372T3 (da) 2005-09-19
AU2001289606A1 (en) 2002-01-02
US20030166718A1 (en) 2003-09-04
EP1294372B1 (de) 2005-08-17
US6919093B2 (en) 2005-07-19
CN102151247A (zh) 2011-08-17
SK762003A3 (en) 2003-07-01

Similar Documents

Publication Publication Date Title
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
DE69925133D1 (de) Pyrrolobenzodiazepine
NO20024099D0 (no) Lavdose entecavir-formulering og anvendelse
HUP0302991A3 (en) Isoxazoles and their use as inhibitors of erk and pharmaceutical compositions containing the compounds
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
HUP0204071A3 (en) Nitrogenous cyclic compounds and pharmaceutical compositions containing the same and their use
MXPA03007140A (es) Derivados de carbolina.
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
NO20022525L (no) Farmasöytiske formuleringer inneholdende zolmitriptan
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
PL366855A1 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
DE60013486D1 (de) Verbindungen
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
HK1040196A1 (zh) 低劑量艾替開韋製劑及其應用
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
ATE295154T1 (de) Zusammensetzungen mit langsamer freigabe enthaltend lithium-carbonat
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
ES2159479A1 (es) Nuevos indazoles como inhibidores de la ciclooxigenasa-ii
NO20015207L (no) Anvendelse av antiprogestagener i kombinert terapi
AU2001219672A1 (en) Phenoxyethyl-thiourea-pyridine compounds and their use for the treatment of hiv-infections
ECSP972253A (es) Composicion farmaceutica: nueva formulacion y su uso en el tratamiento y/o profilaxis de ciertos trastornos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition